European VCs help biotech firm raise $43m

Four European venture capital funds have contributed to a $43m (€49.3m) financing for Agensys, a US biotechnology firm, in a deal highlighting the sector's popularity.

In one of the largest venture capital financings this year, European investors HBM, Lombard Odier, Carnegie and BSI joined a syndicate of 10 institutional investors in the private placing for Agensys, which develops cancer treatments.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump